MeMed logo
page-image.jpg

Learn about MeMed BV® and MeMed Key®

immune response technology at booth #4448

MeMed is transforming patient care by listening to the immune system and turning host response signals into clinical action.

AACC Poster Presentations

gruppe.jpg
Dr-Einav-Simon.png
arrow

Dr. Einav Simon

Director of R&D Clinical Science, MeMed

B-239
MeMed BV Distinguishes Between Viral and Bacterial Infection in Sepsis Patients

Session: B / Microbiology and Infectious Diseases

Date: Wednesday, July 27, 2022
Poster Presentation: 1:30 – 2:30 PM

Display: 9:30 AM - 5:00 PM

Dr. Theresa Jacob

Director, Clinical Trials Unit & Translational Research, Maimonides Medical Center

arrow

B-203
Host-Protein Score (Integrating TRAIL, IP-10, CRP) Distinguishes Between Viral and Viral-Bacterial Co-infection in Adult Patients Testing Positive for Viral Detection

Session: B / Microbiology and Infectious Diseases

Date: Wednesday, July 27, 2022
Poster Presentation: 1:30 – 2:30 PM

Display: 9:30 AM - 5:00 PM

How it Works

About MeMed

At MeMed, a leader in host response technologies, we decode the body's complex signals into simple insights that improve people's lives. By leveraging our expertise in host-response profiling and machine-learning algorithms, we are creating a portfolio of tests that address tough clinical dilemmas.

 

Importantly, with the support of public and private partnerships, we have developed a point-of-need, rapid measurement platform called MeMed Key to ensure timely availability of these novel tests during the clinician’s decision-making workflow.

Contact Us

arrow&v
arrow&v
arrow&v
  • YouTube
  • LinkedIn
  • Twitter
Memed logo

©MeMed 2022 All rights reserved | Privacy Policy | Terms of Use